查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1941762

出血性中风治疗设备市场规模、份额和趋势分析报告：按治疗类型、最终用途、地区和细分市场预测（2026-2033 年）

Hemorrhagic Stroke Treatment Devices Market Size, Share & Trends Analysis Report By Treatment Type, By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

出血性中风治疗设备市场概述

预计到 2025 年，全球出血性中风治疗设备市场规模将达到 11.9 亿美元，到 2033 年将达到 20.8 亿美元。

预计从 2026 年到 2033 年，该行业将以 7.24% 的复合年增长率成长。推动该行业发展的因素是脑出血和脑动脉瘤发病率的上升，尤其是在老年人口和高血压患者中。

微创介入神经放射学普及和综合中风中心的扩建进一步推动了市场需求。此外，技术进步、临床疗效的改善以及先进医疗体系下的报销支持也促进了市场成长。脑出血和脑动脉瘤发生率的上升导致需要紧急医疗干预的患者数量增加，直接推动了对出血性中风治疗设备的需求。随着确诊病例的增多，医疗机构正在采用先进的血管内和微创技术来改善治疗效果，这不仅推动了市场成长，也促进了治疗方案的持续创新和投资。

欧洲多个国家持续报告出血性中风的严重负担，这推动了市场预计成长。

根据世界卒中组织发布的《2025年全球卒中概况》，每年新增卒中病例将超过1200万例，全球约四分之一的人一生中会经历卒中。报告也显示，脑出血（ICH）占所有中风病例的28.8%，蜘蛛网膜下腔出血（SAH）占5.8%，显示出血性中风的负担极为沉重。预计该疾病盛行率的不断上升将成为预测期内推动市场成长的主要因素。

根据美国心臟协会2022年2月发布的数据，出血性中风约占美国每年报告的约80万例中风病例的10%，且与其他类型中风相比，其死亡率往往更高。这种沉重的疾病负担预计将推动对出血性中风治疗设备的需求。

目录

第一章调查方法和范围

第二章执行摘要

第三章 出血性中风治疗器械市场变数、趋势与范围

  • 市场谱系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
  • 出血性中风治疗设备市场分析工具
    • 波特分析
    • PESTEL 分析

第四章 出血性中风治疗设备市场：依治疗类型分類的估算与趋势分析

  • 全球出血性中风治疗设备市场：按治疗类型分類的变化分析（2025 年和 2033 年）
  • 全球出血性中风治疗设备市场规模及趋势分析（依治疗类型划分，2021-2033 年）
  • 动脉瘤和出血性中风治疗性介入
    • 指示
    • 透过处理设备
  • 脑血管成形术和血管重塑
    • 球囊血管成形术系统
    • 颅内和颈动脉支架系统
    • 线圈辅助装置（球囊辅助装置及支架辅助装置）
  • 辅助和手术通道设备
    • 引导管和远端通路导管
    • 微导管
    • 检修鞘套和电线

第五章 出血性中风治疗设备市场：依最终用途分類的估算与趋势分析

  • 全球出血性中风治疗设备市场：按最终用途分類的变化分析（2025 年和 2033 年）
  • 全球出血性中风治疗设备市场规模及趋势分析（依最终用途划分，2021-2033 年）
  • 医院
  • 专业神经外科中心
  • 门诊手术中心

第六章 出血性中风治疗设备市场：按治疗类型、最终用途和地区分類的估算和趋势分析

  • 区域仪錶板
  • 市场规模及趋势分析，2021-2033年
  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 丹麦
    • 挪威
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争情势

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 2025年企业市场占有率分析
  • 公司热力图分析
  • 策略规划
    • 业务拓展
    • 併购
    • 伙伴关係与合作
    • 引入新的治疗方法
    • 研究与开发
  • 公司简介
    • Medtronic
    • MicroVention, Inc. (Terumo Corporation)
    • Balt
    • Scientia Vascular, Inc.
    • MicroPort Scientific Corporation
    • Johnson & Johnson (MedTech)
    • phenox GmbH (Wallaby Medical)
    • Acandis GmbH
    • B. Braun SE
    • Integra LifeSciences
    • Infinity Neuro LLC
    • Penumbra, Inc.
    • Boston Scientific Corporation
    • Stryker
    • Peter LAZIC GmbH
Product Code: GVR-4-68040-841-5

Hemorrhagic Stroke Treatment Devices Market Summary

The global hemorrhagic stroke treatment devices market size was valued at USD 1.19 billion in 2025 and is projected to reach USD 2.08 billion by 2033, growing at a CAGR of 7.24% from 2026 to 2033. The industry is driven by the rising incidence of intracerebral hemorrhage and cerebral aneurysms, particularly among aging populations and patients with hypertension.

Increasing adoption of minimally invasive neurointerventional procedures and expansion of comprehensive stroke centers are further boosting demand. In addition, technological advancements, improving clinical outcomes, and supportive reimbursement in developed healthcare systems are accelerating market growth. The rising incidence of intracerebral hemorrhage and cerebral aneurysms increases the number of patients requiring urgent medical intervention, directly boosting demand for hemorrhagic stroke treatment devices. As more cases are diagnosed, healthcare providers adopt advanced endovascular and minimally invasive technologies to improve outcomes, which in turn drives market growth and encourages continued innovation and investment in treatment solutions.

Multiple countries across Europe continue to report a significant hemorrhagic stroke burden, contributing to anticipated market expansion.

According to the Global Stroke Fact Sheet 2025 published by the World Stroke Organization, more than 12 million new stroke cases occur annually, and nearly one in four people worldwide will experience a stroke during their lifetime. The report indicates that intracerebral hemorrhage (ICH) accounts for 28.8% and subarachnoid hemorrhage (SAH) for 5.8% of all incident strokes, underscoring the substantial hemorrhagic stroke burden. The growing prevalence of this disease is anticipated to be a key factor supporting market growth during the forecast period.

According to data published by the American Heart Association in February 2022, hemorrhagic strokes account for approximately 10% of the nearly 800,000 stroke cases reported annually in the U.S., and they are associated with a higher mortality rate compared to other stroke types. This considerable disease burden is anticipated to drive demand for hemorrhagic stroke treatment devices.

Hemorrhagic Stroke Treatment Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global hemorrhagic stroke treatment devices market report on the basis of treatment type, end use, and region:

  • Treatment Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Aneurysm & Hemorrhagic Stroke Interventions
    • By Indication
    • Intracranial Aneurysm
    • cSDH (MMA Embolization)
    • AVM & AVF Embolization
    • By Device
    • Embolization Coiling Systems
    • Bare Platinum Coils
    • Coated / Bioactive Coils
    • Flow Diversion Systems
    • Standard Flow-Diverting Stents (e.g., Pipeline)
    • Next-Generation / Surface-Modified Flow Diverters
    • Intrasaccular Flow Disruption Devices
    • Woven EndoBridge (WEB)
    • Contour Neurovascular System
    • Luna Aneurysm Embolization System
    • Liquid Embolization Agents
    • Non-Adhesive Liquid Embolics (Onyx, Squid, PHIL)
    • Adhesive Liquid Embolics (NBCA)
  • Cerebral Angioplasty & Vascular Remodeling
    • Balloon Angioplasty Systems
    • Intracranial & Carotid Stenting Systems
    • Coil-Assisted Adjunctive Devices (Balloon-assisted and stent-assisted)
  • Ancillary & Procedural Access Devices
    • Guiding & Distal Access Catheters
    • Microcatheters
    • Access Sheaths & Wires
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Specialty Neurosurgery Centers
  • Ambulatory Surgical Centers
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Treatment Type
    • 1.1.2. End Use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Details of primary research
    • 1.5.1. Data for primary interviews in North America
    • 1.5.2. Data for primary interviews in Europe
    • 1.5.3. Data for primary interviews in Asia Pacific
    • 1.5.4. Data for primary interviews in Latin America
    • 1.5.5. Data for Primary interviews in MEA
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
      • 1.7.1.1. Approach 1: Commodity flow approach
    • 1.7.2. Volume price analysis (Model 2)
      • 1.7.2.1. Approach 2: Volume price analysis
  • 1.8. Research Scope and Assumptions
    • 1.8.1. List of Secondary Sources
    • 1.8.2. List of Primary Sources
    • 1.8.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Hemorrhagic Stroke Treatment Devices Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Rising prevalence of intracranial aneurysms and hemorrhagic stroke
      • 3.2.1.2. Advancements in neurointerventional technologies
      • 3.2.1.3. Growing adoption of endovascular procedures
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. High cost of devices and procedures
      • 3.2.2.2. Limited availability of skilled neurointerventional specialists
    • 3.2.3. Market Opportunity Analysis
      • 3.2.3.1. Technological innovation in minimally invasive neurointerventional devices
      • 3.2.3.2. Rising public awareness about hemorrhagic stroke
      • 3.2.3.3. Increasing clinical trials
      • 3.2.3.4. Expansion of stroke care infrastructure in emerging markets
      • 3.2.3.5. Rising stroke incidence among younger adults
    • 3.2.4. Market Challenge Analysis
      • 3.2.4.1. Complications associated with neurovascular treatments
      • 3.2.4.2. Balancing innovation with safety requirements
  • 3.3. Hemorrhagic Stroke Treatment Devices Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal landscape

Chapter 4. Hemorrhagic Stroke Treatment Devices Market: Treatment Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Hemorrhagic Stroke Treatment Devices Market: Treatment Type Movement Analysis, 2025 & 2033 (USD Million)
  • 4.3. Global Hemorrhagic Stroke Treatment Devices Market Size & Trend Analysis, by Treatment Type, 2021 to 2033 (USD Million)
  • 4.4. Aneurysm & Hemorrhagic Stroke Interventions
    • 4.4.1. Aneurysm & hemorrhagic stroke interventions market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. By indication
      • 4.4.2.1. By indication market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.2.2. Intracranial aneurysm
        • 4.4.2.2.1. Intracranial aneurysm market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.2.3. cSDH (MMA Embolization)
        • 4.4.2.3.1. cSDH (MMA Embolization) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.2.4. AVM & AVF embolization
        • 4.4.2.4.1. AVM & AVF embolization market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. By device
      • 4.4.3.1. By device market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.2. Embolization coiling systems
        • 4.4.3.2.1. Embolization coiling systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.4.3.2.2. Bare Platinum Coils
          • 4.4.3.2.2.1. Bare Platinum Coils market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.4.3.2.3. Coated / Bioactive Coils
          • 4.4.3.2.3.1. Coated / Bioactive Coils market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.3. Flow diversion systems
        • 4.4.3.3.1. Flow diversion systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.4.3.3.2. Standard Flow-Diverting Stents (e.g., Pipeline)
          • 4.4.3.3.2.1. Standard Flow-Diverting Stents (e.g., Pipeline) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.4.3.3.3. Next-Generation / Surface-Modified Flow Diverters
          • 4.4.3.3.3.1. Next-Generation / Surface-Modified Flow Diverters market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.4. Intrasaccular flow disruption devices
        • 4.4.3.4.1. Intrasaccular flow disruption devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.4.3.4.2. Woven EndoBridge (WEB)
          • 4.4.3.4.2.1. Woven EndoBridge (WEB) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.4.3.4.3. Contour Neurovascular System
          • 4.4.3.4.3.1. Contour Neurovascular System market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.4.3.4.4. Luna Aneurysm Embolization System
          • 4.4.3.4.4.1. Luna Aneurysm Embolization System market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.5. Liquid embolization agents
        • 4.4.3.5.1. Liquid embolization agents market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.4.3.5.2. Non-Adhesive Liquid Embolics (Onyx, Squid, PHIL)
          • 4.4.3.5.2.1. Non-Adhesive Liquid Embolics (Onyx, Squid, PHIL) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.4.3.5.3. Adhesive Liquid Embolics (NBCA)
          • 4.4.3.5.3.1. Adhesive Liquid Embolics (NBCA) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5. Cerebral Angioplasty & Vascular Remodeling
    • 4.5.1. Cerebral angioplasty & vascular remodeling market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.2. Balloon angioplasty systems
      • 4.6.2.1. Balloon angioplasty systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.3. Intracranial & carotid stenting systems
      • 4.6.3.1. Intracranial & carotid stenting systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.4. Coil-assisted adjunctive devices (Balloon-assisted and stent-assisted)
      • 4.6.4.1. Coil-assisted adjunctive devices (Balloon-assisted and stent-assisted) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.6. Ancillary & procedural access devices
    • 4.6.1. Ancillary & procedural access devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.6.2. Guiding & distal access catheters
      • 4.7.2.1. Guiding & distal access catheters market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.6.3. Microcatheters
      • 4.7.3.1. Microcatheters market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.6.4. Access sheaths & wires
      • 4.7.4.1. Access sheaths & wires market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Hemorrhagic Stroke Treatment Devices Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Hemorrhagic Stroke Treatment Devices Market: End use Movement Analysis, 2025 & 2033 (USD Million)
  • 5.3. Global Hemorrhagic Stroke Treatment Devices Market Size & Trend Analysis, by End use 2021 to 2033 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5. Specialty Neurosurgery Centers
    • 5.5.1. Specialty neurosurgery centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.6. Ambulatory Surgical Centers
    • 5.6.1. Ambulatory surgical centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Hemorrhagic Stroke Treatment Devices Market: Regional Estimates & Trend Analysis by Treatment Type, and End Use

  • 6.1. Regional Dashboard
  • 6.2. Market Size and Trend Analysis, 2021 to 2033
  • 6.3. North America
    • 6.3.1. North America hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Competitive scenario
      • 6.3.2.3. Regulatory framework
      • 6.3.2.4. Reimbursement scenario
      • 6.3.2.5. U.S. hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Competitive scenario
      • 6.3.3.3. Regulatory framework
      • 6.3.3.4. Reimbursement scenario
      • 6.3.3.5. Canada hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.3.4. Mexico
      • 6.3.4.1. Key country dynamics
      • 6.3.4.2. Competitive scenario
      • 6.3.4.3. Regulatory framework
      • 6.3.4.4. Reimbursement scenario
      • 6.3.4.5. Mexico hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.4. Europe
    • 6.4.1. Europe hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.2. UK
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Competitive scenario
      • 6.4.2.3. Regulatory framework
      • 6.4.2.4. Reimbursement scenario
      • 6.4.2.5. UK hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Competitive scenario
      • 6.4.3.3. Regulatory framework
      • 6.4.3.4. Reimbursement scenario
      • 6.4.3.5. Germany hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. France
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Competitive scenario
      • 6.4.4.3. Regulatory framework
      • 6.4.4.4. Reimbursement scenario
      • 6.4.4.5. France hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Competitive scenario
      • 6.4.5.3. Regulatory framework
      • 6.4.5.4. Reimbursement scenario
      • 6.4.5.5. Italy hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Competitive scenario
      • 6.4.6.3. Regulatory framework
      • 6.4.6.4. Reimbursement scenario
      • 6.4.6.5. Spain hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Competitive scenario
      • 6.4.7.3. Regulatory framework
      • 6.4.7.4. Reimbursement scenario
      • 6.4.7.5. Sweden hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Competitive scenario
      • 6.4.8.3. Regulatory framework
      • 6.4.8.4. Reimbursement scenario
      • 6.4.8.5. Denmark hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.9. Norway
      • 6.4.9.1. Key country dynamics
      • 6.4.9.2. Competitive scenario
      • 6.4.9.3. Regulatory framework
      • 6.4.9.4. Reimbursement scenario
      • 6.4.9.5. Norway hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Asia Pacific hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Competitive scenario
      • 6.5.2.3. Regulatory framework
      • 6.5.2.4. Reimbursement scenario
      • 6.5.2.5. China hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.5.3. Japan
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Competitive scenario
      • 6.5.3.3. Regulatory framework
      • 6.5.3.4. Reimbursement scenario
      • 6.5.3.5. Japan hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.5.4. India
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Competitive scenario
      • 6.5.4.3. Regulatory framework
      • 6.5.4.4. Reimbursement scenario
      • 6.5.4.5. India hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.5.5. South Korea
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Competitive scenario
      • 6.5.5.3. Regulatory framework
      • 6.5.5.4. Reimbursement scenario
      • 6.5.5.5. South Korea hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.5.6. Australia
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Competitive scenario
      • 6.5.6.3. Regulatory framework
      • 6.5.6.4. Reimbursement scenario
      • 6.5.6.5. Australia hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.5.7. Thailand
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Competitive scenario
      • 6.5.7.3. Regulatory framework
      • 6.5.7.4. Reimbursement scenario
      • 6.5.7.5. Thailand hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Latin America hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Competitive scenario
      • 6.6.2.3. Regulatory framework
      • 6.6.2.4. Reimbursement scenario
      • 6.6.2.5. Brazil hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Competitive scenario
      • 6.6.3.3. Regulatory framework
      • 6.6.3.4. Reimbursement scenario
      • 6.6.3.5. Argentina hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.7. Middle East and Africa
    • 6.7.1. Middle East and Africa hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Competitive scenario
      • 6.7.2.3. Regulatory framework
      • 6.7.2.4. Reimbursement scenario
      • 6.7.2.5. South Africa hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.7.3. Saudi Arabia
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Competitive scenario
      • 6.7.3.3. Regulatory framework
      • 6.7.3.4. Reimbursement scenario
      • 6.7.3.5. Saudi Arabia hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Competitive scenario
      • 6.7.4.3. Regulatory framework
      • 6.7.4.4. Reimbursement scenario
      • 6.7.4.5. UAE hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Competitive scenario
      • 6.7.5.3. Regulatory framework
      • 6.7.5.4. Reimbursement scenario
      • 6.7.5.5. Kuwait hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Market Share Analysis, 2025
  • 7.4. Company Heat Map Analysis
  • 7.5. Strategy Mapping
    • 7.5.1. Expansion
    • 7.5.2. Mergers & Acquisition
    • 7.5.3. Partnerships & Collaborations
    • 7.5.4. New Treatment Type Launches
    • 7.5.5. Research And Development
    • 7.5.6. Company Profiles
    • 7.5.7. Medtronic
      • 7.5.7.1. Company overview
      • 7.5.7.2. Financial performance
      • 7.5.7.3. Treatment Type Benchmarking
      • 7.5.7.4. Strategic initiatives
    • 7.5.8. MicroVention, Inc. (Terumo Corporation)
      • 7.5.8.1. Company overview
      • 7.5.8.2. Financial performance
      • 7.5.8.3. Treatment Type Benchmarking
      • 7.5.8.4. Strategic initiatives
    • 7.5.9. Balt
      • 7.5.9.1. Company overview
      • 7.5.9.2. Financial performance
      • 7.5.9.3. Treatment Type Benchmarking
      • 7.5.9.4. Strategic initiatives
    • 7.5.10. Scientia Vascular, Inc.
      • 7.5.10.1. Company overview
      • 7.5.10.2. Financial performance
      • 7.5.10.3. Treatment Type Benchmarking
      • 7.5.10.4. Strategic initiatives
    • 7.5.11. MicroPort Scientific Corporation
      • 7.5.11.1. Company overview
      • 7.5.11.2. Financial performance
      • 7.5.11.3. Treatment Type Benchmarking
      • 7.5.11.4. Strategic initiatives
    • 7.5.12. Johnson & Johnson (MedTech)
      • 7.5.12.1. Company overview
      • 7.5.12.2. Financial performance
      • 7.5.12.3. Treatment Type Benchmarking
      • 7.5.12.4. Strategic initiatives
    • 7.5.13. phenox GmbH (Wallaby Medical)
      • 7.5.13.1. Company overview
      • 7.5.13.2. Financial performance
      • 7.5.13.3. Treatment Type Benchmarking
      • 7.5.13.4. Strategic initiatives
    • 7.5.14. Acandis GmbH
      • 7.5.14.1. Company overview
      • 7.5.14.2. Financial performance
      • 7.5.14.3. Treatment Type Benchmarking
      • 7.5.14.4. Strategic initiatives
    • 7.5.15. B. Braun SE
      • 7.5.15.1. Company overview
      • 7.5.15.2. Financial performance
      • 7.5.15.3. Treatment Type Benchmarking
      • 7.5.15.4. Strategic initiatives
    • 7.5.16. Integra LifeSciences
      • 7.5.16.1. Company overview
      • 7.5.16.2. Financial performance
      • 7.5.16.3. Treatment Type Benchmarking
      • 7.5.16.4. Strategic initiatives
    • 7.5.17. Infinity Neuro LLC
      • 7.5.17.1. Company overview
      • 7.5.17.2. Financial performance
      • 7.5.17.3. Treatment Type Benchmarking
      • 7.5.17.4. Strategic initiatives
    • 7.5.18. Penumbra, Inc.
      • 7.5.18.1. Company overview
      • 7.5.18.2. Financial performance
      • 7.5.18.3. Treatment Type Benchmarking
      • 7.5.18.4. Strategic initiatives
    • 7.5.19. Boston Scientific Corporation
      • 7.5.19.1. Company overview
      • 7.5.19.2. Financial performance
      • 7.5.19.3. Treatment Type Benchmarking
      • 7.5.19.4. Strategic initiatives
    • 7.5.20. Stryker
      • 7.5.20.1. Company overview
      • 7.5.20.2. Financial performance
      • 7.5.20.3. Treatment Type Benchmarking
      • 7.5.20.4. Strategic initiatives
    • 7.5.21. Peter LAZIC GmbH
      • 7.5.21.1. Company overview
      • 7.5.21.2. Financial performance
      • 7.5.21.3. Treatment Type Benchmarking
      • 7.5.21.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America hemorrhagic stroke treatment devices market, by region, 2021 - 2033 (USD Million)
  • Table 3 North America hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 4 North America hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 5 U.S. hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 6 U.S. hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 7 Canada hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 8 Canada hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 9 Mexico hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 10 Mexico hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 11 Europe hemorrhagic stroke treatment devices market, by region, 2021 - 2033 (USD Million)
  • Table 12 Europe hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 13 Europe hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 14 Germany hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 15 Germany hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 16 UK hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 17 UK hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 18 France hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 19 France hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 20 Italy hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 21 Italy hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 22 Spain hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 23 Spain hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 24 Denmark hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 25 Denmark hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 26 Sweden hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 27 Sweden hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 28 Norway hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 29 Norway hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 30 Asia Pacific hemorrhagic stroke treatment devices market, by region, 2021 - 2033 (USD Million)
  • Table 31 Asia Pacific hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 32 Asia Pacific hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 33 China hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 34 China hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 35 Japan hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 36 Japan hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 37 India hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 38 India hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 39 South Korea hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 40 South Korea hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 41 Australia hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 42 Australia hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 43 Thailand hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 44 Thailand hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 45 Latin America hemorrhagic stroke treatment devices market, by region, 2021 - 2033 (USD Million)
  • Table 46 Latin America hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 47 Latin America hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 48 Brazil hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 49 Brazil hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 50 Argentina hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 51 Argentina hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 52 MEA hemorrhagic stroke treatment devices market, by region, 2021 - 2033 (USD Million)
  • Table 53 MEA hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 54 MEA hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 55 South Africa hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 56 South Africa hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 57 Saudi Arabia hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 58 Saudi Arabia hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 59 UAE hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 60 UAE hemorrhagic stroke treatment devices market, by application, 2021 - 2033 (USD Million)
  • Table 61 UAE hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 62 Kuwait hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 63 Kuwait hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Hemorrhagic stroke treatment devices market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Data analysis models
  • Fig. 5 Market formulation and validation
  • Fig. 6 Data validating & publishing
  • Fig. 7 Market snapshot
  • Fig. 8 Segment snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Hemorrhagic stroke treatment devices - market size and growth prospects (USD million)
  • Fig. 11 Hemorrhagic stroke treatment devices market: Industry Value Chain Analysis
  • Fig. 12 Hemorrhagic stroke treatment devices market: Market Dynamics
  • Fig. 13 Hemorrhagic stroke treatment devices market: PORTER's Analysis
  • Fig. 14 Hemorrhagic stroke treatment devices market: PESTEL Analysis
  • Fig. 15 Hemorrhagic stroke treatment devices market share by treatment type, 2025 & 2033 (USD Million)
  • Fig. 16 Hemorrhagic stroke treatment devices market, by treatment type: market share, 2023 & 2030
  • Fig. 17 Aneurysm & hemorrhagic stroke interventions market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 18 By indication market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 19 Intracranial aneurysm market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 20 cSDH (MMA Embolization) market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 21 AVM & AVF embolization market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 22 By device market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 23 Embolization coiling systems market share by treatment type, 2025 & 2033 (USD Million)
  • Fig. 24 Bare platinum coils market share by treatment type, 2025 & 2033 (USD Million)
  • Fig. 25 Coated / bioactive coils market share by treatment type, 2025 & 2033 (USD Million)
  • Fig. 26 Flow diversion systems market share by treatment type, 2025 & 2033 (USD Million)
  • Fig. 27 Standard flow-diverting stents (e g , pipeline) market share by treatment type, 2025 & 2033 (USD Million)
  • Fig. 28 Next-generation / surface-modified flow diverters market share by treatment type, 2025 & 2033 (USD Million)
  • Fig. 29 Intrasaccular flow disruption devices market share by treatment type, 2025 & 2033 (USD Million)
  • Fig. 30 Woven endobridge (WEB) market share by treatment type, 2025 & 2033 (USD Million)
  • Fig. 31 Luna aneurysm embolization system market share by treatment type, 2025 & 2033 (USD Million)
  • Fig. 32 Liquid embolization agents market share by treatment type, 2025 & 2033 (USD Million)
  • Fig. 33 Non-adhesive liquid embolics (onyx, squid, PHIL) market share by treatment type, 2025 & 2033 (USD Million)
  • Fig. 34 Adhesive liquid embolics (NBCA) market share by treatment type, 2025 & 2033 (USD Million)
  • Fig. 35 Cerebral angioplasty & vascular remodeling market share by treatment type, 2025 & 2033 (USD Million)
  • Fig. 36 Balloon angioplasty systems market share by treatment type, 2025 & 2033 (USD Million)
  • Fig. 37 Intracranial & carotid stenting systems market share by treatment type, 2025 & 2033 (USD Million)
  • Fig. 38 Coil-assisted adjunctive devices (balloon-assisted and stent-assisted) market share by treatment type, 2025 & 2033 (USD Million)
  • Fig. 39 Ancillary & procedural access devices market share by treatment type, 2025 & 2033 (USD Million)
  • Fig. 40 Guiding & distal access catheters market share by treatment type, 2025 & 2033 (USD Million)
  • Fig. 41 Microcatheters market share by treatment type, 2025 & 2033 (USD Million)
  • Fig. 42 Access sheaths & wires market share by treatment type, 2025 & 2033 (USD Million)
  • Fig. 43 Hemorrhagic stroke treatment devices market share by end use, 2025 & 2033 (USD Million)
  • Fig. 44 Hemorrhagic stroke treatment devices market, by end use: market share, 2023 & 2030
  • Fig. 45 Hospitals market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 46 Specialty neurosurgery centers market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 47 Ambulatory surgical centers market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 48 Regional marketplace: key takeaways
  • Fig. 49 North America hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 U S hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Canada hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Mexico hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Europe hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 UK hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033,) (USD Million)
  • Fig. 55 Germany hemorrhagic stroke treatment devices market estimates and forecasts, (2021 - 2033,) (USD Million)
  • Fig. 56 France hemorrhagic stroke treatment devices market estimates and forecasts, (2021 - 2033,) (USD Million)
  • Fig. 57 Italy hemorrhagic stroke treatment devices market estimates and forecasts, (2021 - 2033,) (USD Million)
  • Fig. 58 Spain hemorrhagic stroke treatment devices market estimates and forecasts, (2021 - 2033,) (USD Million)
  • Fig. 59 Sweden hemorrhagic stroke treatment devices market estimates and forecasts, (2021 - 2033,) (USD Million)
  • Fig. 60 Denmark hemorrhagic stroke treatment devices market estimates and forecasts, (2021 - 2033,) (USD Million)
  • Fig. 61 Norway hemorrhagic stroke treatment devices market estimates and forecasts, (2021 - 2033,) (USD Million)
  • Fig. 62 Asia Pacific hemorrhagic stroke treatment devices market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 63 China hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Japan hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 India hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 South Korea hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Australia hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Thailand hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Latin America hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Brazil hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Argentina hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 MEA hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 South Africa hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Saudi Arabia hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 UAE hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Kuwait hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 Key company categorization
  • Fig. 78 Company market positioning
  • Fig. 79 Key company market share analysis, 2025
  • Fig. 80 Strategic framework